GDNF and Parkinson disease: The potential for trophic factors to protect nigrostriatal neurons in PD has been extensively explored in recent years, with the GDNF family ligands, GDNF and NTN, advancing to clinical trials that have all ultimately failed to provide significant clinical improvement in PD subjects61–66.